Ocular surface disease during dupilumab treatment in patients with atopic dermatitis, is it possible to prevent it?-Reference-Cited by-同舟云学术

Ocular surface disease during dupilumab treatment in patients with atopic dermatitis, is it possible to prevent it?

Published:2020-02-13 Issue:6 Volume:34 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Pistone G.¹,Tilotta G.¹,Gurreri R.¹,Castelli E.¹,Curiale S.¹,Bongiorno M.R.¹^ORCID

Affiliation:

1. Section of Dermatology Department of Health Promotion Maternal‐Infant, Internal Medicine and Specialization of Excellence “G. D'Alessandro” (PROMISE) University of Palermo Palermo Italy

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.16234

Reference7 articles.

1. Biological therapies for atopic dermatitis: an update;Deleanu D;Exp Ther Med,2019

2. Real‐life practice: rapid improvement in itch symptomatology in patients with atopic dermatitis treated with dupilumab;Pistone G;J Dermatolog Treat,2019

3. Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion

4. Dupilumab ocular surface disease occurs predominantly in patients receiving dupilumab for atopic dermatitis: A multi-institution retrospective chart review

5. Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin-17 levels?: reply from the authors

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dupilumab for the treatment of prurigo nodularis: A systematic review;Frontiers in Immunology;2023-01-20

2. Atopic dermatitis diagnosis and treatment consensus report;TURKDERM;2022-12-05

3. Dupilumab‐associated ocular surface disease: An interdisciplinary decision framework for prescribers in the Australian setting;Australasian Journal of Dermatology;2022-09-20

4. Staying ahead of dupilumab-associated ocular surface disease;Canadian Eye Care Today;2022-09-01

5. Dupilumab ocular side effects in patients with atopic dermatitis: a systematic review;Journal of the European Academy of Dermatology and Venereology;2022-02-17